|
| |
| | | 70187 | | 23.07.2025 | | Amgen Switzerland AG | | | | | | | 22.07.2030 | | | | | | | | | | 07.15. | | |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Wezenla 130 mg/26 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Ustekinumabum 130mg / 26ml) | L04AC05 | |
|
|
|
